La stratégie algérienne de lutte contre le cancer repose sur « la prévention et le traitement »
Summary of Algeria’s Cancer Prevention and Treatment Strategy
At a recent conference in Algiers focused on cancer prevention and treatment, Algeria’s Minister of Health, Abdelhak Saihi, outlined the country’s comprehensive strategy aimed at combating cancer through both prevention and treatment. Since 2020, Algeria has adopted a dual-pronged approach involving significant investments in healthcare infrastructure and resources.
Healthcare Infrastructure and Equipment
Minister Saihi emphasized substantial efforts in enhancing hospitals and healthcare facilities, equipping them with advanced medical equipment to alleviate patient suffering. Currently, Algeria has 21 cancer treatment centers (CACs) dedicated to providing care for cancer patients. Notably, the healthcare system has seen the introduction of chemotherapy across various medical establishments, with half of the pharmacy budget allocated for cancer-specific medications.
Investment in Technology
Saihi reported that Algeria has secured 62 radiation accelerators to improve cancer treatment, with an additional 29 expected to be operational in the upcoming year. This not only strengthens the country’s ability to treat cancer but also reflects a commitment to tackle the disease’s root causes, focusing on lifestyle factors such as diet and environmental pollution.
Role of the Ministry of Labor
Fayçal Bentaleb, the Minister of Labor, Employment, and Social Security, highlighted the ministry’s integral role in supporting cancer patients. The ministry provides financial assistance related to screening and treatment, alongside awareness campaigns. Notably, the “Chifa” card offers free medication coverage to 2,158 cancer patients not enrolled in social security, representing a financial commitment of approximately 57 million Algerian Dinars.
Regulatory Developments
Bentaleb also discussed the ongoing work to draft an executive decree establishing a standard agreement between social security organizations and private oncology centers, particularly benefiting children with cancer. This decree would regulate insurance expenses related to radiotherapy, including accommodation and transportation services.
Pharmaceutical Industry Contributions
Ouacim Kouidri, the Minister of Pharmaceutical Industry, committed to addressing recommendations from the conference that emphasize developing cancer medications and ensuring their availability. He underscored the importance of innovative drugs and plans to register medications included in national healthcare programs, facilitating patient access to groundbreaking treatments.
Higher Education and Research Initiatives
Minister of Higher Education and Scientific Research, Kamel Baddari, announced the intention to establish a collaborative agreement with the National Commission for Cancer Prevention and Control (CNPLCC). This agreement aims to promote research and education focused on cancer prevention, detection, and medication development. Algeria currently boasts three active research centers, 24 research laboratories, and 15 nationwide projects, with plans for 12 new projects dedicated to cancer research.
Support in Education
Minister of National Education, Mohammed Seghir Sadaoui, presented initiatives to support students diagnosed with cancer. These efforts include adapting educational programs and creating specialized classes within hospitals, ensuring continuity in education despite health challenges.
Overall, Algeria’s approach to cancer management reflects a holistic commitment, integrating healthcare, education, and community support to improve outcomes for patients. The collaborative efforts among various ministries signify a national resolve to combat cancer and enhance the quality of life for affected individuals. Through robust infrastructure, financial assistance, innovative research, and educational support, Algeria aims to address the complexities of cancer treatment effectively.
